PDF(804 KB)
The application progress of amyloid protein PET-CT in the diagnosis and treatment evaluation of Alzheimer's disease
Xifen GONG, Xiaofeng LI
Chinese Journal of Alzheimer's Disease and Related Disorders ›› 2026, Vol. 9 ›› Issue (5) : 357-361.
PDF(804 KB)
Abbreviation (ISO4): Chinese Journal of Alzheimer's Disease and Related Disorders
Editor in chief: Jun WANG
PDF(804 KB)
The application progress of amyloid protein PET-CT in the diagnosis and treatment evaluation of Alzheimer's disease
Alzheimer's disease (AD) is a common neurodegenerative disorder characterized pathologically by the deposition of senile plaques and neurofibrillary tangles, with biochemical alterations involving abnormal accumulation of β-amyloid (Aβ) and hyperphosphorylation of TAU protein in the brain. As an advanced molecular imaging technique, positron emission tomography-computed tomography (PET-CT) enables non-invasive, high-resolution visualization of the spatiotemporal distribution patterns of Aβ deposition. This review summarizes the current applications of amyloid PET-CT in the diagnosis and treatment of AD, including its capability for early detection of Aβ deposition, dynamic tracking of spatiotemporal Aβ changes, comparison with other diagnostic methods, correlation with Tau PET-CT findings, role in therapeutic evaluation, as well as its limitations and future prospects, aiming to provide direction for clinical management and research in AD.
PET-CT / Alzheimer's disease / Amyloid beta protein / Diagnosis / Treatment
| [1] |
|
| [2] |
|
| [3] |
|
| [4] |
|
| [5] |
|
| [6] |
|
| [7] |
|
| [8] |
|
| [9] |
|
| [10] |
|
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
|
| [18] |
|
| [19] |
|
| [20] |
|
| [21] |
|
| [22] |
|
| [23] |
|
| [24] |
|
| [25] |
|
| [26] |
|
| [27] |
|
| [28] |
|
| [29] |
|
| [30] |
|
| [31] |
|
| [32] |
|
| [33] |
|
| [34] |
|
| [35] |
|
利益冲突声明 所有作者在本研究中均不存在利益冲突。
/
| 〈 |
|
〉 |